243 - (Steward)Ships Across the Water: Pediatric AMS in the U.S. and Europe

Saturday, October 19, 2024

1:45 PM – 3:00 PM US PT

Location: 502 A

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

William Steinbach, MD

Robert H. Fiser, Jr., MD Endowed Chair in Pediatrics Chair, Department of Pediatrics Associate Dean for Child Health College of Medicine, University of Arkansas for Medical Sciences Pediatrician-in-Chief, Arkansas Children’s
Arkansas Children's, University of Arkansas for Medical Sciences
Little Rock, AR, United States
Sarah Parker, MD

Professor of Pediatric Infectious Diseases
Pediatrics
University of Colorado/Children's Hospital Colorado
Aurora, CO, United States
Adilia Warris, MD, PhD (she/her/hers)

Co-director
MRC Centre for Medical Mycology, University of Exeter
Exeter, England, United Kingdom

Faculty(s)

Lilliam Ambroggio, PhD (she/her/hers)

Associate Professor of Pediatrics
Children's Hospital Colorado
Aurora, CO, United States
Elisa Barbieri, PharmD, PhD (she/her/hers)

Post-Doc Researcher
University of Padova, Italy, Italy
SK

Sarah Kabbani, MD, MSc

Physician, Public Health
DHQP
Centers for Disease Control and Prevention
Atlanta, Georgia, United States
Stéphane Paulus, MD, FRCPCH (he/him/his)

Consultant in Paediatric Infectious Diseases
Oxford University Hospitals

Disclosure(s):

William Steinbach, MD: No financial relationships to disclose

Sarah K. Parker, MD: Colorado Department of Health and Environment: Advisor/Consultant (Ongoing); Pfizer Global Bridges: Grant/Research Support (Ongoing)

Adilia Warris, MD, PhD: Gilead Sciences: Honoraria (Terminated); Pfizer, Inc.: Advisor/Consultant (Terminated)

Lilliam Ambroggio, PhD: Pfizer, Inc.: Grant/Research Support (Ongoing)

Elisa Barbieri, PharmD, PhD: Sanofi and AstraZeneca: Travel grant (Terminated, May 31, 2024)

Sarah Kabbani, MD, MSc: No financial relationships to disclose

Stéphane Paulus, MD, FRCPCH: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe antibiotic use globally in emergency medicine and inpatient settings for pediatric patients;
describe pediatric stewardship practices in europe: what the us and europe can learn from one another;
analyze antibiotic use in the united states for pediatric patients.

Presentations:

1:45 PM – 2:03 PM US PT

The Antibiotic Prescribing Landscape for Pediatrics in the US
Speaker: Sarah Kabbani, MD, MSc – Centers for Disease Control and Prevention
2:03 PM – 2:21 PM US PT

Sharing European Challenges and Successes in Pediatric Antimicrobial Stewardship
Speaker: Elisa Barbieri, PharmD, PhD (she/her/hers) – University of Padova, Italy
2:21 PM – 2:39 PM US PT

Sharing European Challenges and Successes in Pediatric Antimicrobial Stewardship: Europe and the UK
Speaker: Stéphane Paulus, MD, FRCPCH (he/him/his) – Oxford University Hospitals
2:39 PM – 3:00 PM US PT

The Antibiotic Prescribing Landscape for Children Globally
Speaker: Lilliam Ambroggio, PhD (she/her/hers) – Children's Hospital Colorado